You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

recurrent bladder cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bladder Cancer Trial (Multi4)

Not yet recruiting
  • Bladder Cancer
  • Multi4
  • (no location specified)
Nov 14, 2023

Non-muscle-invasive Bladder Cancer Trial (STM-416)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
  • (no location specified)
Jan 25, 2023

Recurrent Bladder Cancer Trial (FPA144)

No longer available
  • Recurrent Bladder Cancer
  • (no location specified)
Dec 9, 2021

Bladder Cancer, Recurrent Bladder Cancer, FGFR3 Gene Mutation Trial in United States (Erdafitinib)

Recruiting
  • Bladder Cancer
  • +2 more
  • Basking Ridge, New Jersey
  • +6 more
Aug 22, 2022

Bladder Cancer Trial in Tianjin (Cadonilimab)

Recruiting
  • Bladder Cancer
  • Tianjin, Tianjin, China
    Tianjin Medical University Second Hospital
Aug 23, 2023

Recurrent or Metastatic Bladder Cancer Trial in Shanghai (Chimeric exosomal tumor vaccines)

Recruiting
  • Recurrent or Metastatic Bladder Cancer
  • Chimeric exosomal tumor vaccines
  • Shanghai, China
    Fudan University Pudong Medical Center
Sep 26, 2022

Non-Muscle Invasive Bladder Cancer Trial in Aarhus (Laser ablation)

Recruiting
  • Non-Muscle Invasive Bladder Cancer
  • Laser ablation
  • Aarhus, Denmark
    Aarhus University Hospital
Aug 5, 2022

Recurrent Bladder Carcinoma, Stage 0a Bladder Urothelial Carcinoma, Stage 0is Bladder Urothelial Carcinoma Trial in Chicago (BCG

Active, not recruiting
Has Results
  • Recurrent Bladder Carcinoma
  • +3 more
  • BCG Solution
  • +3 more
  • Chicago, Illinois
    Northwestern University
Sep 27, 2022

Recurrent Bladder Carcinoma, Bladder Cancer Stage 0, Bladder Cancer Stage I Trial in Los Angeles (Pharmacokinetic Study,

Not yet recruiting
  • Recurrent Bladder Carcinoma
  • +2 more
  • Pharmacokinetic Study
  • Recombinant EphB4-HSA Fusion Protein
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Jan 31, 2023

Non-muscle Invasive Bladder Cancer, NMIBC, Carcinoma in Situ of Bladder Trial in United States (UGN-301, UGN-201)

Recruiting
  • Non-muscle Invasive Bladder Cancer
  • +5 more
  • Little Rock, Arkansas
  • +7 more
Dec 19, 2022

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Not yet recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +31 more
  • Diagnostic Laboratory Biomarker Analysis
  • Nivolumab
  • Houston, Texas
    M D Anderson Cancer Center
Aug 18, 2022

Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

Recruiting
  • Locally Advanced Bladder Urothelial Carcinoma
  • +18 more
  • Los Angeles, California
  • +2 more
Jun 28, 2022

Bladder Cancer, Bladder Cancer Recurrent, Tumor Recurrence Trial (Bacillus Calmette-Guerin: Strain Russian BCG-I, Bacillus

Not yet recruiting
  • Bladder Cancer
  • +5 more
  • Bacillus Calmette-Guerin: Strain Russian BCG-I
  • Bacillus Calmette-Guerin: Strain TICE
  • (no location specified)
Apr 7, 2022

Bladder Cancer Trial in Korea, Republic of, Poland, United States (PF-07225570, sasanlimab)

Recruiting
  • Bladder Cancer
  • New York, New York
  • +5 more
Jun 28, 2022

Bladder Cancer Trial in Minsk (Dendritic cells, Standard treatment according to the Clinical protocols)

Completed
  • Bladder Cancer
  • Dendritic cells
  • Standard treatment according to the Clinical protocols
  • Minsk, Belarus
    Institute of Biophysics and Cell Engineering of National Academy
Jan 20, 2021

Bladder Urothelial Carcinoma In Situ, Recurrent Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8 Trial in Seattle

Recruiting
  • Bladder Urothelial Carcinoma In Situ
  • +5 more
  • Acupuncture Therapy
  • +4 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
May 27, 2022

Blood and Tissue Samples From Locally Recurrent or Metastatic

Recruiting
  • Localized Renal Pelvis and Ureter Urothelial Carcinoma
  • +10 more
  • Cytology Specimen Collection Procedure
  • Laboratory Biomarker Analysis
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Dec 21, 2021

Distal Urethral Cancer, Proximal Urethral Cancer, Recurrent Bladder Cancer Trial in United States (afatinib dimaleate,

Recruiting
  • Distal Urethral Cancer
  • +8 more
  • afatinib dimaleate
  • laboratory biomarker analysis
  • Atlanta, Georgia
  • +5 more
Sep 24, 2021

Bladder Cancer Recurrent, Non-Invasive Bladder Urothelial Carcinoma Trial in Ankara, Istanbul, Izmir

Recruiting
  • Bladder Cancer Recurrent
  • Non-Invasive Bladder Urothelial Carcinoma
    • Ankara, Turkey
    • +2 more
    Apr 10, 2022

    Advanced Bladder Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, Metastatic Bladder Urothelial Carcinoma Trial in

    Recruiting
    • Advanced Bladder Urothelial Carcinoma
    • +23 more
    • Riverside, California
    • +8 more
    Jul 16, 2022

    Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter

    Recruiting
    • Locally Advanced Bladder Urothelial Carcinoma
    • +13 more
    • Atlanta, Georgia
      Emory University Hospital/Winship Cancer Institute
    Jun 8, 2022

    Intravesical Therapy and Surgery as Treatment Options for

    Recruiting
    • Bladder Cancer
    • +2 more
      • Birmingham, Alabama
      • +37 more
      Nov 28, 2022

      Triple Negative Breast Cancer, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (ONM-501, Cemiplimab)

      Not yet recruiting
      • Triple Negative Breast Cancer
      • +13 more
      • (no location specified)
      Aug 29, 2023

      Biliary Tract Cancer, Cholangiocarcinoma, Gall Bladder Cancer Trial (CTX-009, Paclitaxel)

      Not yet recruiting
      • Biliary Tract Cancer
      • +3 more
      • (no location specified)
      Aug 16, 2022

      Bladder Cancer Trial in Germany, Switzerland (VPM1002BC)

      Active, not recruiting
      • Bladder Cancer
      • Freiburg, Germany
      • +15 more
      Feb 3, 2022